Eligo Bioscience (France)

Recent papers from Eligo Bioscience (France)

1. Treatment of Shiga toxin–producing E. coli infection by CRISPR-Cas–targeted cleavage of the Shiga toxin gene in animal modelsScience Translational Medicine · 2026
2. Circularization of 23S rRNA but not 16S rRNA within archaeal ribosomesGenome biology · 2026
3. Lysosomal Ion Channels and Transporters: Recent Findings, Therapeutic Potential, and Technical ApproachesBioelectricity · 2025
4. Treatment of STEC infection via CRISPR-Cas targeted cleavage of the Shiga toxin gene in animal models2025
5. In situ targeted base editing of bacteria in the mouse gutNature · 2024
6. Multiomics approaches disclose very-early molecular and cellular switches during insect-venom allergen-specific immunotherapy2024
7. PI4KIIIβ inhibition reduces rhinovirus associated cell shedding and ciliary dysfunction2023
8. Early-to-mid stage idiopathic Parkinson’s disease shows enhanced cytotoxicity and differentiation in CD8 T-cells in femalesNature Communications · 2023
9. In situ targeted mutagenesis of gut bacteria2022
10. Distinct eosinophil subsets are modulated by agonists of the commensal-metabolite and vitamin B3 receptor GPR109A during allergic-type inflammation2022
11. Phages and their satellites encode hotspots of antiviral systemsCell Host & Microbe · 2022
12. PI3Kδ inhibition prevents IL33, ILC2s and inflammatory eosinophils in persistent airway inflammationBMC Immunology · 2021
13. Physiologically Based Pharmacokinetic Modelling of Inhaled Nemiralisib: Mechanistic Components for Pulmonary Absorption, Systemic Distribution, and Oral AbsorptionClinical Pharmacokinetics · 2021
14. Genetic determinism of phage-bacteria coevolution in natural populations2021